메뉴 건너뛰기




Volumn 8, Issue 5, 2007, Pages 209-213

Drugs affecting coagulation

Author keywords

direct thrombin inhibitors; fondaparinux; glycoprotein IIb IIIa antagonists; heparin; warfarin

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANISTREPLASE; ANTICOAGULANT AGENT; ARGATROBAN; CILOSTAZOL; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; IDRAPARINUX; LANOTEPLASE; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; RAZAXABAN; RETEPLASE; STREPTOKINASE; THROMBIN INHIBITOR; TICLOPIDINE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; UROKINASE; WARFARIN; XIMELAGATRAN;

EID: 34247594397     PISSN: 14720299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpaic.2007.02.002     Document Type: Review
Times cited : (2)

References (1)
  • 1
    • 19944432311 scopus 로고    scopus 로고
    • PERSIST Investigators: a novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis: a Phase II evaluation
    • (Erratum in:Blood2002;100:82a)
    • PERSIST Investigators: a novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis: a Phase II evaluation. J Thromb Haemost 2 (2004) 47-53 (Erratum in:Blood2002;100:82a)
    • (2004) J Thromb Haemost , vol.2 , pp. 47-53


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.